Lightnews — Scholar-powered news

Andrew Lloyd ALA @andrewlloydala.bsky.social · 9h

[ALA client news] Avec le soutien de ses actionnaires historiques Téthys Invest, CVC et La Caisse (ex-CDPQ), Sebia annonce l’entrée en négociations exclusives en vue d’accueillir Warburg Pincus à son capital

#diagnostic #oncologie ala.associates/corporate/se...

Avec le soutien de ses actionnaires historiques – Téthys Invest, CVC et La Caisse (précédemment CDPQ) – Sebia est heureux d’annoncer l’entrée en négociations exclusives en vue d’accueillir Warburg Pin...

ala.associates

Andrew Lloyd ALA @andrewlloydala.bsky.social · 2d

[ALA client news] Ciliatech opens US subsidiary and plans clinical trials in #glaucoma

Initiative follows recent CE mark of Ciliatech’s flagship eye implant, a novel treatment for patients with mild to moderate glaucoma

#glaucoma #USsubsidiary #clinicalresearch

ala.associates/corporate/ci...

Ciliatech opens US subsidiary and plans clinical trials in glaucoma | Andrew Lloyd & Associates

ala.associates

Andrew Lloyd ALA @andrewlloydala.bsky.social · 7d

🔬 From flexible implants to circuits seeded with living cells, a new kind of electronics is starting to produce long-lasting implants with the potential to help everything from paralysis to hearing and vision loss - @newscientist.com

www.newscientist.com/article/2492...

#technology #medtech

The futuristic new tech that could bridge broken nerves and mend minds

From flexible implants to circuits seeded with living cells, a new kind of electronics is starting to produce long-lasting implants with the potential to help everything from paralysis to hearing and ...

www.newscientist.com

2

Andrew Lloyd ALA @andrewlloydala.bsky.social · 14d

Ciloa’s story was picked up in 50+ international and industry-specific publications, including @lesechosfr.bsky.social, EU Startups, The Pharma Letter and Actu fr 🌍

Full case study👇
ala.associates/case-studies...

Want to learn how we can help your startup? DM us!💬
#PR #biotech #diabetes

Ciloa | Andrew Lloyd & Associates

Ciloa is a pioneer in the bioengineering of extracellular vesicles to develop new generations of therapeutics and preventive solutions to improve patients’ lives.

ala.associates

Andrew Lloyd ALA @andrewlloydala.bsky.social · 14d

At ALA, we’re proud to partner with Ciloa, a biotech pioneer engineering small extracellular vesicles (sEVs) for therapeutic and preventive use 🧬

We helped raise awareness of its €6.5M funding for advancement of its therapeutic option for metabolic diseases, such as #diabetes and #obesity💡

1 1

Andrew Lloyd ALA @andrewlloydala.bsky.social · 15d

[ALA Client News] SeaBeLife secures €2 million

☑️ This funding will help fast-track the launch of clinical trials in dry AMD and severe acute hepatitis programs, with first clinical trial set to start in 2026

ala.associates/funding/seab...

#ophthalmology #funding #biotech

1

Andrew Lloyd ALA @andrewlloydala.bsky.social · 17d

[ALA Client News] RDS raises €14 million to industrialize MultiSense®,
a connected patch for remote patient monitoring

ala.associates/funding/rds-...

#medtech #funding #wearables

1

Andrew Lloyd ALA @andrewlloydala.bsky.social · 22d

[ALA Client News] Sonomind secures €3 million to advance its novel neuromodulation ultrasound device and opens a new therapeutic pathway in psychiatry and neurology

ala.associates/funding/sono...

@cnrs.fr @espciparispsl.bsky.social

#neurology #funding #neuromodulation #depression

1 2

Andrew Lloyd ALA @andrewlloydala.bsky.social · 28d

🖨️ #3DPrinting: Electronic devices that dissolve in water could make it easier to create and recycle technology prototypes – and they could even inspire more sustainable commercial devices - @jeremyhsu.bsky.social for @newscientist.com

www.newscientist.com/article/2493...

#sustainability

3D-printed electronics can dissolve in water for quick recycling

Electronic devices that dissolve in water could make it easier to create and recycle technology prototypes – and they could even inspire more sustainable commercial devices

www.newscientist.com

2

Andrew Lloyd ALA @andrewlloydala.bsky.social · Sep 16

[ALA Client News] Genoskin Raises $8.7M Series A to Advance Ethical, Human Based Models That Deliver Reliable Insights for Safer, More Predictive Drug Development

ala.associates/funding/geno...

#drugdevelopment #immunotoxicology #funding

Andrew Lloyd ALA @andrewlloydala.bsky.social · Sep 15

[ALA Client News] SOM Biotech receives positive EMA COMP opinion on European Orphan Drug Designation for SOM3355 for treatment of Huntington’s Disease

👉 ala.associates/regulatory/s...

#huntingtonsdisease #neurology

Andrew Lloyd ALA @andrewlloydala.bsky.social · Sep 12

#Biotech #PR #Ophthalmology #Oncology #ALS

1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Sep 12

5️⃣ Naobios, Nuvonis and European Vaccine Initiative (EVI) talked about challenge agents with Josh Abbott for BioProcess International

1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Sep 12

4️⃣ Ciliatech in Ophthalmology Times Europe. Ciliatech co-founders Olivier Benoit (CEO) and Philippe Sourdille spoke with Hattie Hayes about the CE Mark for the company's implant, Intercil Uveal Spacer, for #glaucoma.

1 1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Sep 12

3️⃣ Meteor Biotech in @firstwordgroup.com HealthTech. Meteor's new generation spatial biology platform, CosmoSort was installed at Magnify, the @cnsiatucla.bsky.social (CNSI) incubator site, and location of the company's newly created US office

1 1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Sep 12

2️⃣ Roca Therapeutics in La Tribune. The company has secured the first ever @ema.europa.eu recognition of radiation maculopathy as a distinct indiction as well as orphan drug designation for RCT002, a first-in-class eye-drop therapy

1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Sep 12

Celebrating our clients' media successes🌟

Here are some of our recent highlights:

1️⃣ PLL Therapeutics in Drug Discovery World. PLL' CEO Jean-Pascal Zambaux presented the company's strategic approach for early detection and treatment of Amyotrophic Lateral Sclerosis (ALS) at Bioshares Biotech Summit

1 1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Sep 2

[ALA Client News] Naobios, Nuvonis and European Vaccine Initiative collaborate on manufacturing influenza challenge agent

ala.associates/partnership/...

#biotech #vaccines

1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Aug 28

[ALA Client News] BioWin Days 2025
: Belgian health innovators set to meet on September 23 and 24

ala.associates/events/belgi...

#biotech #healthtech

1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Aug 27

[ALA Client News] Ciliatech obtains CE mark for eye implant Intercil® Uveal Spacer, novel treatment for patients with glaucoma

ala.associates/regulatory/c...

#Ophthalmology #Glaucoma #CEmark #ESCRS #MedTech

1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Aug 26

[ALA Client News] Meteor Biotech installs spatial biology platform, CosmoSort, at Magnify, CNSI incubator on UCLA campus

ala.associates/partnership/...

#SpatialCellSorting #DrugDevelopment #Oncology #Immunology #Neurology

Andrew Lloyd ALA @andrewlloydala.bsky.social · Aug 26

[ALA Client News] Roca Therapeutics secures first-ever @ema.europa.eu recognition of Radiation Maculopathy as distinct indication - and Orphan Drug Designation

ala.associates/regulatory/r...

#Oncology #ClinicalTrials #Opthalmology #Radiotherapy

Andrew Lloyd ALA @andrewlloydala.bsky.social · Aug 19

Researchers have developed antibiotics that can potentially kill drug-resistant gonorrhoea and MRSA with the help of artificial intelligence - @the-independent.com

www.independent.co.uk/news/science...

#antibiotics #antimicrobialresistance #AI

Scientists use AI to create antibiotics for deadly gonorrhoea and MRSA superbugs

Antimicrobial resistance is a growing public health crisis and is estimated to be responsible for more than one million deaths globally each year

www.independent.co.uk

1 1

Andrew Lloyd ALA @andrewlloydala.bsky.social · Aug 14

Scientists say this could be the start of a "new generation" of tech, capable of hacking the gut microbiome

www.sciencefocus.com/news/gut-mic...

#microbiome #guthealth #healthtech

New smart pill could let doctors explore and treat your gut from the inside | BBC Science Focus Magazine

Scientists have found a way to control gut bacteria from a smartphone

www.sciencefocus.com

Andrew Lloyd ALA @andrewlloydala.bsky.social · Aug 7

Scientists have found the first robust evidence that genes affect chances of #ME/CFS, a mysterious and debilitating illness that has been neglected and dismissed for decades by many in the medical community - @iansample.bsky.social for @theguardian.com

www.theguardian.com/society/2025...

Scientists find link between genes and ME/chronic fatigue syndrome

Large study suggests people’s genetics could ‘tip the balance’ on whether they would develop the illness

www.theguardian.com

1 1